文献速递肿瘤 PET/CT核素与放射性配体治疗

[18F]F-FAPI PET/CT、[18F]F-FDG PET/CT与磁化传递MR成像检测克罗恩病肠纤维化的对比分析:前瞻性动物模型与人类队列研究

Comparative analysis of [18F]F-FAPI PET/CT, [18F]F-FDG PET/CT and magnetization transfer MR imaging to detect intestinal fibrosis in Crohn's disease: A prospective animal model and human cohort study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2024-02-15

研究采用22只TNBS诱导纤维化大鼠模型和10例克罗恩病患者的34处肠道狭窄,前瞻性比较[18F]F-FAPI PET/CT、[18F]F-FDG PET/CT与磁化传递MR成像(MTI)检测肠纤维化的诊断效能。患者中FAPI摄取区分非轻度与中重度纤维化的AUC均为0.87,高于FDG(AUC均为0.82),与MTI(AUC为0.90)相当。大鼠中FAPI摄取较FDG和MTI更早反映纤维化发展。

要点

  • 患者中FAPI摄取区分非轻度与中重度纤维化的AUC均为0.87,高于FDG(AUC均为0.82),与MTI(AUC为0.90)相当。
  • 大鼠中FAPI摄取较FDG和MTI更早反映纤维化发展,早期与病理纤维化相关性更强(SUVmean R=0.69)。
  • FAPI PET/CT诊断克罗恩病纤维化效能优于FDG PET/CT,与MTI相当,对早期检测有较大潜力。

核心结论

  • [18F]F-FAPI PET/CT检测克罗恩病纤维化的诊断效能优于[18F]F-FDG PET/CT,与MTI相当,对早期检测肠纤维化表现出较大潜力。

研究设计与样本

  • 前瞻性动物模型与人类队列研究:22只大鼠经TNBS处理模拟纤维化发展,一周内进行三次定量成像。
  • 前瞻性招募10例克罗恩病患者共34处肠道狭窄,采用相同成像方案验证诊断效能。

主要发现

  • 在克罗恩病患者中,FAPI摄取区分非轻度与中重度纤维化的AUC均为0.87(均P≤0.01),高于FDG摄取(AUC均为0.82,P≤0.01),与MTI(AUC为0.90,P≤0.001)相当。
  • 在大鼠中,FAPI摄取较FDG和MTI更早反映纤维化发展。
  • 大鼠早期阶段,FAPI摄取与病理纤维化相关性更强(SUVmean:R=0.69),高于FDG(SUVmean:R=0.17)和MTI(R=0.52)。

关键数值与推荐

  • 患者中FAPI摄取区分非轻度与中重度纤维化的AUC均为0.87(均P≤0.01)。
  • 患者中FDG摄取区分非轻度与中重度纤维化的AUC均为0.82(P≤0.01)。
  • 患者中MTI区分非轻度与中重度纤维化的AUC为0.90(P≤0.001)。
  • 大鼠早期FAPI摄取SUVmean与病理纤维化R=0.69,FDG SUVmean R=0.17,MTI R=0.52。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Accurately and early detection of intestinal fibrosis in Crohn's disease (CD) is crucial for clinical management yet remains an unmet need. Fibroblast activation protein inhibitor (FAPI) PET/CT has emerged as a promising tool to assess fibrosis. We aimed to investigate the diagnostic capability of [18F]F-FAPI PET/CT in detecting intestinal fibrosis and compared it with[18F]F-FDG PET/CT and magnetization transfer MR imaging (MTI). METHODS: Twenty-two rats underwent TNBS treatment to simulate fibrosis development, followed by three quantitative imaging sessions within one week. Mean and maximum standardized uptake values (SUVmean and SUVmax) were calculated on[18F]F-FAPI and [18F]F-FDG PET/CT, along with normalized magnetization transfer ratio on MTI. Intestinal fibrosis was assessed pathologically, with MTI serving as imaging standard for fibrosis. The diagnostic efficacy of imaging parameters in fibrosis was compared using pathological and imaging standards. Ten patients with 34 bowel strictures were prospectively recruited to validate their diagnostic performance, using the identical imaging protocol. RESULTS: In CD patients, the accuracy of FAPI uptake (both AUCs = 0.87, both P ≤ 0.01) in distinguishing non-to-mild from moderate-to-severe fibrosis was higher than FDG uptake (both AUCs = 0.82, P ≤ 0.01) and comparable to MTI (AUCs = 0.90, P ≤ 0.001). In rats, FAPI uptake responded earlier to fibrosis development than FDG and MTI; consistently, during early phase, FAPI uptake showed a stronger correlation (SUVmean: R = 0.69) with pathological fibrosis than FDG (SUVmean: R = 0.17) and MTI (R = 0.52). CONCLUSION: The diagnostic efficacy of [18F]F-FAPI PET/CT in detecting CD fibrosis is superior to [18F]F-FDG PET/CT and comparable to MTI, exhibiting great potential for early detection of intestinal fibrosis.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Li Z, Chen Z, Zhang R, et al. Comparative analysis of [18F]F-FAPI PET/CT, [18F]F-FDG PET/CT and magnetization transfer MR imaging to detect intestinal fibrosis in Crohn's disease: A prospective animal model and human cohort study. Eur J Nucl Med Mol Imaging. 2024. PMID: 38355741. doi:10.1007/s00259-024-06644-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。